Trial Profile
Non-intervention study of apatinib combined with capecitabine versus capecitabine in the treatment of advanced metastatic colorectal cancer
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 19 Jan 2018
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary) ; Capecitabine
- Indications Colorectal cancer
- Focus Therapeutic Use
- 19 Jan 2018 New trial record